Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy
Abstract Background Out of the myriad of complications associated with septic shock, septic-associated encephalopathy (SAE) carries a significant risk of morbidity and mortality. Blood-brain-barrier (BBB) impairment, which subsequently leads to increased vascular permeability, has been associated wi...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12974-019-1689-8 |
id |
doaj-2ca3bb7c0f154de581947c56a975439a |
---|---|
record_format |
Article |
spelling |
doaj-2ca3bb7c0f154de581947c56a975439a2021-01-31T16:05:02ZengBMCJournal of Neuroinflammation1742-20942020-01-0117111110.1186/s12974-019-1689-8Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathyBereketeab Haileselassie0Amit U. Joshi1Paras S. Minhas2Riddhita Mukherjee3Katrin I. Andreasson4Daria Mochly-Rosen5Department of Chemical and Systems Biology, Stanford University School of MedicineDepartment of Chemical and Systems Biology, Stanford University School of MedicineDepartment of Neurology & Neurological Sciences, Stanford School of MedicineDepartment of Chemical and Systems Biology, Stanford University School of MedicineDepartment of Neurology & Neurological Sciences, Stanford School of MedicineDepartment of Chemical and Systems Biology, Stanford University School of MedicineAbstract Background Out of the myriad of complications associated with septic shock, septic-associated encephalopathy (SAE) carries a significant risk of morbidity and mortality. Blood-brain-barrier (BBB) impairment, which subsequently leads to increased vascular permeability, has been associated with neuronal injury in sepsis. Thus, preventing BBB damage is an attractive therapeutic target. Mitochondrial dysfunction is an important contributor of sepsis-induced multi-organ system failure. More recently, mitochondrial dysfunction in endothelial cells has been implicated in mediating BBB failure in stroke, multiple sclerosis and in other neuroinflammatory disorders. Here, we focused on Drp1-mediated mitochondrial dysfunction in endothelial cells as a potential target to prevent BBB failure in sepsis. Methods We used lipopolysaccharide (LPS) to induce inflammation and BBB disruption in a cell culture as well as in murine model of sepsis. BBB disruption was assessed by measuring levels of key tight-junction proteins. Brain cytokines levels, oxidative stress markers, and activity of mitochondrial complexes were measured using biochemical assays. Astrocyte and microglial activation were measured using immunoblotting and qPCR. Transwell cultures of brain microvascular endothelial cells co-cultured with astrocytes were used to assess the effect of LPS on expression of tight-junction proteins, mitochondrial function, and permeability to fluorescein isothiocyanate (FITC) dextran. Finally, primary neuronal cultures exposed to LPS were assessed for mitochondrial dysfunction. Results LPS induced a strong brain inflammatory response and oxidative stress in mice which was associated with increased Drp1 activation and mitochondrial localization. Particularly, Drp1-(Fission 1) Fis1-mediated oxidative stress also led to an increase in expression of vascular permeability regulators in the septic mice. Similarly, mitochondrial defects mediated via Drp1-Fis1 interaction in primary microvascular endothelial cells were associated with increased BBB permeability and loss of tight-junctions after acute LPS injury. P110, an inhibitor of Drp1-Fis1 interaction, abrogated these defects, thus indicating a critical role for this interaction in mediating sepsis-induced brain dysfunction. Finally, LPS mediated a direct toxic effect on primary cortical neurons, which was abolished by P110 treatment. Conclusions LPS-induced impairment of BBB appears to be dependent on Drp1-Fis1-mediated mitochondrial dysfunction. Inhibition of mitochondrial dysfunction with P110 may have potential therapeutic significance in septic encephalopathy.https://doi.org/10.1186/s12974-019-1689-8Drp1NeuroinflammationBlood brain barrierP110Sepsis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bereketeab Haileselassie Amit U. Joshi Paras S. Minhas Riddhita Mukherjee Katrin I. Andreasson Daria Mochly-Rosen |
spellingShingle |
Bereketeab Haileselassie Amit U. Joshi Paras S. Minhas Riddhita Mukherjee Katrin I. Andreasson Daria Mochly-Rosen Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy Journal of Neuroinflammation Drp1 Neuroinflammation Blood brain barrier P110 Sepsis |
author_facet |
Bereketeab Haileselassie Amit U. Joshi Paras S. Minhas Riddhita Mukherjee Katrin I. Andreasson Daria Mochly-Rosen |
author_sort |
Bereketeab Haileselassie |
title |
Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy |
title_short |
Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy |
title_full |
Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy |
title_fullStr |
Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy |
title_full_unstemmed |
Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy |
title_sort |
mitochondrial dysfunction mediated through dynamin-related protein 1 (drp1) propagates impairment in blood brain barrier in septic encephalopathy |
publisher |
BMC |
series |
Journal of Neuroinflammation |
issn |
1742-2094 |
publishDate |
2020-01-01 |
description |
Abstract Background Out of the myriad of complications associated with septic shock, septic-associated encephalopathy (SAE) carries a significant risk of morbidity and mortality. Blood-brain-barrier (BBB) impairment, which subsequently leads to increased vascular permeability, has been associated with neuronal injury in sepsis. Thus, preventing BBB damage is an attractive therapeutic target. Mitochondrial dysfunction is an important contributor of sepsis-induced multi-organ system failure. More recently, mitochondrial dysfunction in endothelial cells has been implicated in mediating BBB failure in stroke, multiple sclerosis and in other neuroinflammatory disorders. Here, we focused on Drp1-mediated mitochondrial dysfunction in endothelial cells as a potential target to prevent BBB failure in sepsis. Methods We used lipopolysaccharide (LPS) to induce inflammation and BBB disruption in a cell culture as well as in murine model of sepsis. BBB disruption was assessed by measuring levels of key tight-junction proteins. Brain cytokines levels, oxidative stress markers, and activity of mitochondrial complexes were measured using biochemical assays. Astrocyte and microglial activation were measured using immunoblotting and qPCR. Transwell cultures of brain microvascular endothelial cells co-cultured with astrocytes were used to assess the effect of LPS on expression of tight-junction proteins, mitochondrial function, and permeability to fluorescein isothiocyanate (FITC) dextran. Finally, primary neuronal cultures exposed to LPS were assessed for mitochondrial dysfunction. Results LPS induced a strong brain inflammatory response and oxidative stress in mice which was associated with increased Drp1 activation and mitochondrial localization. Particularly, Drp1-(Fission 1) Fis1-mediated oxidative stress also led to an increase in expression of vascular permeability regulators in the septic mice. Similarly, mitochondrial defects mediated via Drp1-Fis1 interaction in primary microvascular endothelial cells were associated with increased BBB permeability and loss of tight-junctions after acute LPS injury. P110, an inhibitor of Drp1-Fis1 interaction, abrogated these defects, thus indicating a critical role for this interaction in mediating sepsis-induced brain dysfunction. Finally, LPS mediated a direct toxic effect on primary cortical neurons, which was abolished by P110 treatment. Conclusions LPS-induced impairment of BBB appears to be dependent on Drp1-Fis1-mediated mitochondrial dysfunction. Inhibition of mitochondrial dysfunction with P110 may have potential therapeutic significance in septic encephalopathy. |
topic |
Drp1 Neuroinflammation Blood brain barrier P110 Sepsis |
url |
https://doi.org/10.1186/s12974-019-1689-8 |
work_keys_str_mv |
AT bereketeabhaileselassie mitochondrialdysfunctionmediatedthroughdynaminrelatedprotein1drp1propagatesimpairmentinbloodbrainbarrierinsepticencephalopathy AT amitujoshi mitochondrialdysfunctionmediatedthroughdynaminrelatedprotein1drp1propagatesimpairmentinbloodbrainbarrierinsepticencephalopathy AT parassminhas mitochondrialdysfunctionmediatedthroughdynaminrelatedprotein1drp1propagatesimpairmentinbloodbrainbarrierinsepticencephalopathy AT riddhitamukherjee mitochondrialdysfunctionmediatedthroughdynaminrelatedprotein1drp1propagatesimpairmentinbloodbrainbarrierinsepticencephalopathy AT katriniandreasson mitochondrialdysfunctionmediatedthroughdynaminrelatedprotein1drp1propagatesimpairmentinbloodbrainbarrierinsepticencephalopathy AT dariamochlyrosen mitochondrialdysfunctionmediatedthroughdynaminrelatedprotein1drp1propagatesimpairmentinbloodbrainbarrierinsepticencephalopathy |
_version_ |
1724316823705354240 |